在B-CPAP中,MAPK通路和NIS在用复星醇治疗的人类乳头甲状腺癌细胞中
Gokcen Unal Kocabas1, Asli Kisim Blatti2, Afig Berdeli3
1Department of Endocrinology and Metabolism, Ege University School of Medicine, Izmir, Turkey.
Pathology, research and practice
|October 15, 2024
概括
ресвератрол通过减少BRAF和ERK的表达和增加NIS的表达来抑制甲状腺癌细胞的增殖. 需要进一步的研究,以探索其对乳头甲状腺癌的治疗潜力.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- Resveratrol是一种天然的植物素,具有已知的抗瘤特性.
- 甲状腺癌细胞是resveratrol潜在治疗效果的目标.
研究的目的:
- 研究复星对BRAF,ERK和NIS的mRNA和蛋白质表达的影响.
- 评估复星对B-CPAP的人类甲状腺 papillary 癌细胞系的影响.
主要方法:
- 在24-72小时内,B-CPAP细胞接受了不同度的白醇 (10-100微米) 治疗.
- 使用XTT测定测量细胞活力.
- 通过rt-PCR和西布洛特分析了BRAF,ERK和NIS的mRNA和蛋白质水平.
主要成果:
- 复星证明了剂量和时间依赖的细胞增殖抑制.
- 观察到BRAF和ERKmRNA和蛋白质水平的显著降低.
- 记录了NIS mRNA和蛋白质表达的显著增加.
结论:
- ресвератрол有效地抑制了乳头甲状腺癌细胞的扩散.
- 该化合物降低了不良预后标志物BRAF和ERK的调节,同时提高了NIS的调节,表明了潜在的重新区分效应.
- 复星需要进一步的研究,作为治疗乳头甲状腺癌的新疗法.
相关概念视频
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
143
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
143


